Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report
Frontiers in Oncology · 20.05.2026 · 16
DOI: 10.3389/fonc.2026.1801452 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.05.2026. Verfasst von Nobuyuki Takahashi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Health Research Promotion Bureau.
Abstract (Originalsprache)
Hematological immune-related adverse events caused by immunotherapy are relatively uncommon. Aplastic anemia triggered by immune checkpoint inhibition is rare and its genomic characteristic remains largely unexplored. This case report describes a 42-year-old female with metastatic cervical cancer who experienced aplastic anemia caused by pembrolizumab. Through a nationwide genomic screening study, MONSTAR-SCREEN-2, we examined genomic landscape of biopsied tissue and circulating tumor DNA. The patient harbored human leukocyte antigen-A*0201 haplotype, which is known as a risk allele of idiopathic acquired aplastic anemia. Clonal hematopoiesis (CH) of myeloid cancer candidate gene DNMT3A c.1429 + 1G>A was newly detected in the buffy-coated white blood cell sample at the time of aplastic anemia diagnosis. This case report contributes to further progress of genomic research of immune-related aplastic anemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
- Minamiakatsuka Clinic, Mito, Japan.
- Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Gynecology, National Cancer Center Hospital East, Kashiwa, Japan.
Förderung
- Japan Health Research Promotion Bureau
Zitieren
APA
Takahashi, N., Harano, K., Funasaka, C., Nakajima, H., Kondoh, C., Matsubara, N., Hosono, A., Naito, Y., Nagamine, M., Tanabe, H., Fujisawa, T., Nakamura, Y., Bando, H., Yoshino, T., Yuda, J., & Mukohara, T. (2026). Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1801452
Vancouver
Takahashi N, Harano K, Funasaka C, Nakajima H, Kondoh C, Matsubara N, et al. Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1801452
BibTeX
@article{Takahashi2026,
author = {Takahashi, Nobuyuki and Harano, Kenichi and Funasaka, Chikako and Nakajima, Hiromichi and Kondoh, Chihiro and Matsubara, Nobuaki and Hosono, Ako and Naito, Yoichi and Nagamine, Michiko and Tanabe, Hiroshi and Fujisawa, Takao and Nakamura, Yoshiaki and Bando, Hideaki and Yoshino, Takayuki and Yuda, Junichiro and Mukohara, Toru},
title = {Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1801452}
}
EUVIMED